George M Jenkins bought $50k of PVLA
director at PIERIS PHARMACEUTICALS, INC.. 445 shares at an average of $112.30, traded Mar 30, 2026, filed Apr 1, 2026.
Score components
- +15RoleDirector
- +7Trade size$50k at market
- -5Relative to holdingsUnder 1% of holdings (0.2%)
- +4Price context25% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- +5Repeat buying2 buys in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +5.4%, 3m +14.9%, 6m +14.6%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-26-038496, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 30, 2026 | POpen-market purchase Common Stock | +445 | $112.30 | $50k | 187,616 | Apr 1, 2026 |
Related signals
Other insiders at PIERIS PHARMACEUTICALS, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 40Moderate | PIERIS PHARMACEUTICALS, INC. | Kathleen Goin Chief Operating Officer | $655k 4,302 shares | -100% | |
| 40Moderate | PIERIS PHARMACEUTICALS, INC. | George M Jenkins director | $4.2M 27,500 shares | -15% | |
| 42Moderate | PIERIS PHARMACEUTICALS, INC. | Christopher P Kiritsy director | $49k 313 shares | -56% | |
| 33Weak | PIERIS PHARMACEUTICALS, INC. | Kathleen Goin Chief Operating Officer | $655k 4,302 shares | -100% | |
| 25Weak | PIERIS PHARMACEUTICALS, INC. | Kathleen Goin Chief Operating Officer | $642k 4,302 shares | -100% | |
| 23Weak | PIERIS PHARMACEUTICALS, INC. | Kathleen Goin Chief Operating Officer | $476k 4,302 shares | -100% | |
| 23Weak | PIERIS PHARMACEUTICALS, INC. | Kathleen Goin Chief Operating Officer | $476k 4,302 shares | -100% | |
| 24Weak | PIERIS PHARMACEUTICALS, INC. | Kathleen Goin Chief Operating Officer | $547k 4,302 shares | -100% | |
| 23Weak | PIERIS PHARMACEUTICALS, INC. | Kathleen Goin Chief Operating Officer | $508k 4,302 shares | -100% | |
| 40Moderate | PIERIS PHARMACEUTICALS, INC. | Elaine J Heron director | $300k 2,400 shares | +5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.